NASDAQ:CMMB | Cash Flow Statement | Chemomab Therapeutics Ltd.

Complete source-backed cash-flow history.

Available history
2018-12-31 to 2025-12-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-06-30-$2.06M
2025-03-31-$3.32M
2024-06-30-$3.63M
2024-03-31-$3.87M
2023-06-30-$7.97M
2023-03-31-$8.75M-$7.19M$1,000.00$14.43M$0.00
2022-12-31-$8.27M-$5.7M$1,000.00$9.35M-$869,000.00
2022-09-30-$8.08M
2022-06-30-$6.19M
2022-03-31-$5.1M-$3.71M$14,000.00$2.38M$0.00
2021-12-31-$5.04M-$2.89M$134,000.00-$19.58M-$81,000.00
2021-09-30-$2.97M
2021-06-30-$2.77M
2021-03-31-$1.7M-$1.29M$3,000.00-$2,000.00$47.8M
2020-12-31-$1.95M-$1.56M$1,000.00-$3,000.00$563,000.00
2020-09-30-$1.22M
2020-06-30-$1.08M
2020-03-31-$1.7M-$1.91M$10,000.00-$10,000.00$500,000.00
2019-12-31-$5.6M-$5.91M-$251,000.00$251,000.00$0.00
2019-09-30-$7.17M
2019-06-30-$4.44M
2019-03-31-$9.91M-$3.12M$75,000.00-$75,000.00$27.82M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$9M-$11.13M$3,000.00$5.39M$7.16M
2024-12-31-$13.95M-$15.39M$0.00$2.3M$9.87M
2023-12-31-$24.22M-$23.61M$3,000.00$15.88M$3.5M
2022-12-31-$27.65M-$20.37M$68,000.00$19.53M-$808,000.00
2021-12-31-$12.48M-$12.37M$239,000.00-$45.19M$61.07M
2020-12-31-$5.95M-$5.24M$38,000.00-$62,000.00$4.75M
2019-12-31-$27.12M-$16.46M$95,000.00-$95,000.00$26.62M
2018-12-31-$13.8M-$14.22M$213,000.00-$213,000.00$20.62M